3. US Guidelines

5. US Guidelines Low-risk Patients

6. GARFIELD Registry

7. Aspirin

8. Aspirin Use in NOAC Trials

9. BAFTA Study Design, Efficacy, and Safety Outcomes

10. AVERROES Efficacy and Safety Outcomes

11. NOACs Bleeding

12. ARISTOTLE Paroxysmal vs Persistent AF Primary Efficacy Outcome

13. ROCKET AF Paroxysmal vs Persistent AF Efficacy and Safety Outcomes

15. NOACs vs Warfarin ICH

16. HAS-BLED Bleeding Risk Score

17. Challenges to OAC Use in Stroke Prevention

19. ROCKET AF Discontinuation Outcomes: Stroke or Non-CNS Embolism

22. Abbreviations

23. Abbreviations (cont)

24. Abbreviations (cont)

25. References

26. References (cont)

27. References (cont)

28. References (cont)

29. References (cont)